3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Thyroid Neoplasms
3
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Tobacco Use Disorder
1
Thyroid Nodule
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Interventions
pembrolizumab
30
Docetaxel
10
Cetuximab
10
Trastuzumab
9
Paclitaxel
7
Nivolumab
6
Magnetic Resonance Spectroscopy
6
palbociclib
5
cemiplimab
5
Gemcitabine
5
Cyclophosphamide
5
Carboplatin
5
Capecitabine
5
Biopsy
5
durvalumab
4
atezolizumab
4
Surveys and Questionnaires
4
Radiotherapy
4
Fulvestrant
4
Fluorodeoxyglucose F18
4
Drug Therapy
4
Cisplatin
4
selpercatinib
3
poly ICLC
3
pazopanib
3
fludarabine
3
avelumab
3
Taxes
3
Sunitinib
3
Specimen Handling
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Molecular Diagnostic Techniques
×
Head & Neck
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled